Form 4: CompoSecure Director Mark R. James Granted Stock Options Valued at $13.68 Per Share
Insider Transaction Report
CompoSecure, Inc. Director Mark R. James was granted 21,074 stock options with an exercise price of $13.68 per share, vesting annually over four years.
Summary
- Mark R. James, a Director of CompoSecure, Inc. (CMPO), was granted 21,074 stock options.
- The stock options have an exercise price of $13.68 per share.
- The transaction date for this grant was May 28, 2025.
- The options will vest in equal annual installments of 25% each, starting on May 28, 2026, and continuing on the first, second, and third anniversaries thereafter.
- The expiration date for these stock options is May 28, 2035.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as the grant of stock options aligns the director's interests with shareholder value, which is generally viewed favorably. However, it is a routine compensation disclosure, not indicative of significant operational or financial news.
Positives
- The grant of stock options to a director aligns management and director interests with those of shareholders, as the value of the options increases with the company's stock price.
- Equity compensation is a standard practice for attracting and retaining qualified board members.
Future Outlook
This filing reports a past transaction and does not contain forward-looking statements or guidance regarding the company's financial performance or strategic outlook.
Industry Context
The granting of stock options to directors is a common practice across various industries as a form of non-cash compensation, aiming to align the interests of the board with long-term shareholder value creation.
Comparison to Industry Standards
- Equity compensation, such as stock options, for non-executive directors is a standard practice in publicly traded companies across most industries, including technology and financial services, to incentivize long-term performance and align interests with shareholders.
- The specific size of the grant (21,074 options) and the vesting schedule (four years, 25% annually) are within typical ranges for director compensation, though specific comparisons would require detailed analysis of CompoSecure's peer group compensation practices.
Related Party Transactions
- The grant of stock options to Mark R. James, a Director of CompoSecure, Inc., constitutes a related party transaction as it involves compensation provided to a member of the company's board of directors.
Stakeholder Impact
- Shareholders: The grant of stock options aims to align the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic oversight.
Next Steps
- The stock options will vest in annual installments of 25% on May 28, 2026, and on the first, second, and third anniversaries thereof.
Key Dates
| Date | Description |
|---|---|
| 05/28/2025 | Date of earliest transaction (stock option grant). |
| 05/30/2025 | Date the Form 4 filing was signed and submitted. |
| 05/28/2026 | First vesting date for 25% of the stock options. |
| 05/28/2027 | Second vesting date for 25% of the stock options. |
| 05/28/2028 | Third vesting date for 25% of the stock options. |
| 05/28/2029 | Fourth and final vesting date for 25% of the stock options. |
| 05/28/2035 | Expiration date of the stock options. |
Keywords
CompoSecure, CMPO, Stock Options, Director Compensation, Insider Transaction, SEC Form 4, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.